Search research articles
Contact Us
Filters
Showing results (191-200 of 617) with videos related to
Page
of 62
Sort By:
Obstetrics and Gynecology
|
April 1, 1997
An outcomes management program in gynecologic oncology
M Morris, C Levenback, T W Burke, et al.
Obstetrics and Gynecology
|
May 1, 1995
Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy
A Bicher, C Levenback, E G Silva, et al.
Gynecologic Oncology
|
March 1, 1994
Enterovesical fistula following radiotherapy for gynecologic cancer
C Levenback, D M Gershenson, R McGehee, et al.
Obstetrics and Gynecology
|
August 1, 1994
Intraoperative lymphatic mapping for vulvar cancer
C Levenback, T W Burke, D M Gershenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design
K R Brader, M Morris, C Levenback, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 1, 1994
Ovarian involvement by serous surface papillary carcinoma
T J Mulhollan, E G Silva, C Tornos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Salvage surgery for chemorefractory gestational trophoblastic disease
E Lehman, D M Gershenson, T W Burke, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 23, 2010
Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Andres G Chiesa, Michael T Deavers, Emanuela Veras, et al.
Cancer Treatment Reviews
|
December 19, 2020
MEK inhibitor resistance mechanisms and recent developments in combination trials
E Kun, Y T M Tsang, C W Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer
S C Modesitt, P Ramirez, Z Zu, et al.
Page
of 62
Search research articles
Search
Showing results (191-200 of 617) with videos related to
Sort By:
Page
of 62
Obstetrics and Gynecology
|
April 1, 1997
An outcomes management program in gynecologic oncology
M Morris, C Levenback, T W Burke, et al.
Obstetrics and Gynecology
|
May 1, 1995
Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy
A Bicher, C Levenback, E G Silva, et al.
Gynecologic Oncology
|
March 1, 1994
Enterovesical fistula following radiotherapy for gynecologic cancer
C Levenback, D M Gershenson, R McGehee, et al.
Obstetrics and Gynecology
|
August 1, 1994
Intraoperative lymphatic mapping for vulvar cancer
C Levenback, T W Burke, D M Gershenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design
K R Brader, M Morris, C Levenback, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 1, 1994
Ovarian involvement by serous surface papillary carcinoma
T J Mulhollan, E G Silva, C Tornos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Salvage surgery for chemorefractory gestational trophoblastic disease
E Lehman, D M Gershenson, T W Burke, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
February 23, 2010
Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Andres G Chiesa, Michael T Deavers, Emanuela Veras, et al.
Cancer Treatment Reviews
|
December 19, 2020
MEK inhibitor resistance mechanisms and recent developments in combination trials
E Kun, Y T M Tsang, C W Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer
S C Modesitt, P Ramirez, Z Zu, et al.
Page
of 62